Overview

• Rep. Ro Khanna has introduced a bipartisan bill to codify President Trump’s executive order on most-favored-nation drug pricing into federal law.
• The legislation aims to ensure Americans pay no more for prescription drugs than people in other developed nations, potentially cutting drug costs by 30–80%.
• Khanna emphasized the need for legislative action to prevent Big Pharma from overturning the executive order through legal challenges, as occurred during Trump’s previous term.
• The bill’s full text has not yet been released, and lawmakers are being solicited for co-sponsorship as the proposal takes shape.
• Big Pharma is expected to mount significant lobbying and legal efforts to counter the legislation, highlighting the ongoing tension between industry interests and consumer protections.